BRCA1 and neoplasm: PARPi have strong cytotoxic effects in tumours harbouring genetic mutations in the components of the DDR system, such as BRCA1, BRCA2, PTEN and XCCR4, due to a mechanism indicated as “synthetic lethality”, according to which the inability to correct PARPi-induced SSBs leads to fatal DNA damage and cellular death (Brown et al. 2017).